On this episode of
Blue Collar ICs, the team breaks down their takeaways from two major conferences—TCT and VIVA—and what the newest technologies could mean for everyday interventional practice. The docs unpack emerging radiation-reduction tools like AeroShield, debate the safety and utility of high-pressure and cutting-balloon strategies, and discuss the evolving role of IVL, atherectomy, and drug-coated balloons. They also dive into the much-talked-about Storm-PE trial and why mechanical thrombectomy may finally have the data it needs to shift PE care nationwide. Along the way, they share candid opinions on bioresorbable scaffolds, clinical trial bottlenecks, and what innovations are truly worth the hype. It’s a fast-moving, highly technical episode full of real-world experience, skepticism, and excitement about where the field is heading next.
Hosted on Acast. See acast.com/privacy for more information.
